83 related articles for article (PubMed ID: 11059685)
1. Long-term follow-up of retroviral vector-administered interferon-gamma (IFN-gamma) gene in metastatic melanoma.
Nemunaitis J; Buchanan A; Jolly DJ
Cancer Gene Ther; 2000 Oct; 7(10):1297-8. PubMed ID: 11059685
[No Abstract] [Full Text] [Related]
2. Phase I trial of interferon-gamma (IFN-gamma) retroviral vector administered intratumorally to patients with metastatic melanoma.
Nemunaitis J; Fong T; Robbins JM; Edelman G; Edwards W; Paulson RS; Bruce J; Ognoskie N; Wynne D; Pike M; Kowal K; Merritt J; Ando D
Cancer Gene Ther; 1999; 6(4):322-30. PubMed ID: 10419050
[TBL] [Abstract][Full Text] [Related]
3. Phase I trial of retroviral vector-mediated interferon (IFN)-gamma gene transfer into autologous tumor cells in patients with metastatic melanoma.
Nemunaitis J; Bohart C; Fong T; Meyer W; Edelman G; Paulson RS; Orr D; Jain V; O'Brien J; Kuhn J; Kowal KJ; Burkeholder S; Bruce J; Ognoskie N; Wynne D; Martineau D; Ando D
Cancer Gene Ther; 1998; 5(5):292-300. PubMed ID: 9824048
[TBL] [Abstract][Full Text] [Related]
4. Postoperative immuno-gene therapy of murine bladder tumor by in vivo administration of retroviruses expressing mouse interferon-gamma.
Shiau AL; Lin CY; Tzai TS; Wu CL
Cancer Gene Ther; 2001 Jan; 8(1):73-81. PubMed ID: 11219496
[TBL] [Abstract][Full Text] [Related]
5. A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma.
Khorana AA; Rosenblatt JD; Sahasrabudhe DM; Evans T; Ladrigan M; Marquis D; Rosell K; Whiteside T; Phillippe S; Acres B; Slos P; Squiban P; Ross M; Kendra K
Cancer Gene Ther; 2003 Apr; 10(4):251-9. PubMed ID: 12679797
[TBL] [Abstract][Full Text] [Related]
6. Phase I trial of interferon gamma retroviral vector administered intratumorally with multiple courses in patients with metastatic melanoma.
Nemunaitis J; Fong T; Burrows F; Bruce J; Peters G; Ognoskie N; Meyer W; Wynne D; Kerr R; Pippen J; Oldham F; Ando D
Hum Gene Ther; 1999 May; 10(8):1289-98. PubMed ID: 10365660
[TBL] [Abstract][Full Text] [Related]
7. Induction of melanoma-associated antigen systemic immunity upon intratumoral delivery of interferon-gamma retroviral vector in melanoma patients.
Fujii S; Huang S; Fong TC; Ando D; Burrows F; Jolly DJ; Nemunaitis J; Hoon DS
Cancer Gene Ther; 2000 Sep; 7(9):1220-30. PubMed ID: 11023194
[TBL] [Abstract][Full Text] [Related]
8. The treatment of established intracranial tumors by in situ retroviral IFN-gamma transfer.
Saleh M; Jonas NK; Wiegmans A; Stylli SS
Gene Ther; 2000 Oct; 7(20):1715-24. PubMed ID: 11083492
[TBL] [Abstract][Full Text] [Related]
9. Phase I study of the intratumoral administration of recombinant canarypox viruses expressing B7.1 and interleukin 12 in patients with metastatic melanoma.
Triozzi PL; Allen KO; Carlisle RR; Craig M; LoBuglio AF; Conry RM
Clin Cancer Res; 2005 Jun; 11(11):4168-75. PubMed ID: 15930353
[TBL] [Abstract][Full Text] [Related]
10. Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma.
Wu A; Oh S; Ericson K; Demorest ZL; Vengco I; Gharagozlou S; Chen W; Low WC; Ohlfest JR
Cancer Gene Ther; 2007 Jun; 14(6):550-60. PubMed ID: 17415381
[TBL] [Abstract][Full Text] [Related]
11. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
12. Rhesus monkey model for fetal gene transfer: studies with retroviral- based vector systems.
Tarantal AF; O'Rourke JP; Case SS; Newbound GC; Li J; Lee CI; Baskin CR; Kohn DB; Bunnell BA
Mol Ther; 2001 Feb; 3(2):128-38. PubMed ID: 11237669
[TBL] [Abstract][Full Text] [Related]
13. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
Choi KJ; Kim JH; Lee YS; Kim J; Suh BS; Kim H; Cho S; Sohn JH; Kim GE; Yun CO
Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479
[TBL] [Abstract][Full Text] [Related]
14. Targeting retroviral integration?
Bushman F
Mol Ther; 2002 Nov; 6(5):570-1. PubMed ID: 12409254
[No Abstract] [Full Text] [Related]
15. Type I IFN innate immune response to adenovirus-mediated IFN-gamma gene transfer contributes to the regression of cutaneous lymphomas.
Urosevic M; Fujii K; Calmels B; Laine E; Kobert N; Acres B; Dummer R
J Clin Invest; 2007 Oct; 117(10):2834-46. PubMed ID: 17823660
[TBL] [Abstract][Full Text] [Related]
16. Immune response induced by retrovirus-mediated HSV-tk/GCV pharmacogene therapy in patients with glioblastoma multiforme.
Rainov NG; Kramm CM; Banning U; Riemann D; Holzhausen HJ; Heidecke V; Burger KJ; Burkert W; Körholz D
Gene Ther; 2000 Nov; 7(21):1853-8. PubMed ID: 11110418
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide analysis of retroviral DNA integration.
Bushman F; Lewinski M; Ciuffi A; Barr S; Leipzig J; Hannenhalli S; Hoffmann C
Nat Rev Microbiol; 2005 Nov; 3(11):848-58. PubMed ID: 16175173
[TBL] [Abstract][Full Text] [Related]
18. The leukemogenic risk of integrating retroviral vectors in hematopoietic stem cell gene therapy applications.
Kang EM; Tisdale JF
Curr Hematol Rep; 2004 Jul; 3(4):274-81. PubMed ID: 15217557
[TBL] [Abstract][Full Text] [Related]
19. Immunity to islet grafts transduced with adenovirus vectors does not inhibit long-term islet function.
Cheng J; Sun J; Sung RS
Transpl Immunol; 2009 May; 21(1):33-42. PubMed ID: 19224710
[TBL] [Abstract][Full Text] [Related]
20. A new generation of retroviral producer cells: predictable and stable virus production by Flp-mediated site-specific integration of retroviral vectors.
Schucht R; Coroadinha AS; Zanta-Boussif MA; Verhoeyen E; Carrondo MJ; Hauser H; Wirth D
Mol Ther; 2006 Aug; 14(2):285-92. PubMed ID: 16697259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]